Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Short interest in First Republic indeed increased as turmoil in the banking sector intensified, although measures vary
The growth could be a challenge in Q1FY24, too, not just because of the cautious customer behavior but also due to the added issue of productivity concessions kicking in, says Nirmal Bang in a note.
Adani Ports, Hindalco among stocks with 100 per cent 'Buy' rating by analysts.
Banks account for most of incremental growth in India Inc earnings
With a modest 1 per cent increase in duty on cigarettes and improving outlook for FMCG and Hotels, brokerages think ITC is well positioned for a strong FY24.
Earlier in November 2022, Morgan Stanley had reiterated its stance on the Indian markets and said that the bull-run remained intact. Back then, they expected the Sensex to hit 80,000 levels by Dec '23
Interest expense rises at fastest clip in 17 quarters in Q3
Company says specialty products will continue as growth driver, will scale up investment for it
In the slow lane: 2.5% rise in profit the least in 10 quarters
Stocks to watch today: Metals and mining major Vedanta will acquire debt-laden power plant Meenakshi Energy for Rs 1,440 crore
Closing Bell: Within sectors, the Nifty metal index closed with most strength, up 1.5 per cent, followed by financials and pharma pockets, while PSB index slumped the most by over 1 per cent
UBS in a note said Morgan Stanley's fourth-quarter core trends were encouraging
The company had posted a Rs 35.65 crore net profit in the year-ago period, according to a statement
CLOSING BELL: Within sectors, barring consumer durables, PSB and Metal indices on the Nifty logged in most gains, up over 1 per cent each, followed by IT and financial pockets
Outlook on margin trajectory, asset quality in Agri/Unsecured book, and commentary around credit cards, traction in fee income, and the merger with HDFC will be the key monitorables, analysts said
CLOSING BELL: Broader markets, too, were subdued in trade as Nifty SmallCap 100 and Nifty MidCap 100 indices slipped up to 0.2 per cent
Closing Bell: Sun Pharma claimed the top winner spot on the Sensex with a gain of 1.7 per cent on launching an anti-cancer drug Palbociclib in India for patients with advanced breast cancer
The biggest gains came to banks, which reported a 35.8 per cent YoY growth rate in their combined net profit in Q2 FY23
The combined net profit of 2,725 listed companies across all sectors was down 6.3 per cent year-on-year (YoY) in Q2 -the first contraction after eight consecutive quarters of YoY growth
Tyre manufacturer MRF Ltd missed second-quarter profit estimates on Tuesday, as soaring input costs and supply chain issues weighed, offsetting a rise in revenue